Meticulous Research® – leading global market research company published a research report titled “Antimicrobial Susceptibility Testing Market by Method (Disk Diffusion, Dilution), Product (Testing Disks, MIC Strips, Automated Systems), Application (Clinical Diagnosis, Drug Discovery), End User (Hospitals, Labs, Pharma Biotech) - Global Forecast to 2025”.

According to this latest publication from Meticulous Research®, the global antimicrobial susceptibility testing market is expected to grow at a CAGR of around 5.6% between 2019-2025 to reach to $3.95 billion by 2025. The high growth of antimicrobial susceptibility testing market is mainly attributed to the rising global incidences of infectious diseases, increased funding and government initiatives, and growing need to address concerns of multidrug resistance. Untapped market potential across emerging economies in APAC and Latin America regions offers significant growth opportunities for the players operating in this market. However, stringent government regulations with unfavorable reimbursement is a key factor expected to hinder the adoption of antimicrobial susceptibility testing products over the coming years.

Request Sample Report:

https://www.meticulousresearch.com/request-sample-report/cp_id=5062

Key Market Segments to Watch

The global antimicrobial susceptibility testing market study presents historical market data in terms of values (2017 and 2018), estimated current data (2019), and forecasts for 2025 - by Product (Manual Antimicrobial Susceptibility Testing, Automated Laboratory Instruments, Consumable& Reagents), by Method (Disk Diffusion, Automated AST, Dilution), by Application (Clinical Diagnosis, Drug Discovery, Epidemiology), End User (Diagnostic Laboratories, Hospitals, Pharma Biotech Industry). The study also evaluates industry competitors and analyzes the market at regional and country level.

On the basis of product, the manual susceptibility testing products segment accounted for the largest share of this market in 2018. Manual testing products are low cost and are easy to use. Thus, these products have high adoption across clinical labs and hospitals, which has led to high market share for this segment. The growth in this market is driven by increasing prevalence of infectious diseases which is driving the demand for susceptibility testing across clinical labs and hospitals.

On the basis of application, the clinical diagnostics segment accounted for the largest share of this market in 2018, owing to the factors such as growing awareness about the use of antimicrobial susceptibility testing methods for diagnostic applications, the rising burden of antimicrobial resistance, and positive government intervention regarding early disease screening.

This research report analyzes major geographies and provides comprehensive analysis for North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, and RoAPAC), Latin America, and Middle East & Africa. North America commanded the largest share of the global antimicrobial susceptibility testing market in 2018, followed by Europe and Asia Pacific regions. Easy accessibility of diagnostic services, high adoption of technologically advanced susceptibility testing methods, and growing focus on addressing the issues of antimicrobial resistance have led to greater share of North America in the global antimicrobial susceptibility testing market. However, Asia Pacific region is expected to grow at the highest CAGR during the forecast period due to the rising prevalence of infectious disease, increasing public health awareness, and increasing consumption of antibiotics which leads to resistance development among the population.

Speak to our expert analyst: 

https://www.meticulousresearch.com/speak-to-analyst/cp_id=5062

The key players operating in the global antimicrobial susceptibility testing market are Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux S.A. (France), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), HiMedia Laboratories (India), MERLIN Diagnostika GmbH (Germany), Accelerate Diagnostics, Inc. (U.S.), Alifax S.r.l. (Italy), Creative Diagnostics (U.S.), Synbiosis (U.K.), and Zhuhai DL Biotech Co., Ltd (China).

Key Topics Covered in This Report:

1.      Introduction

2.      Research Methodology

3.      Executive Summary

4.      Market Share Analysis

5.      Market Insights

6.      Global Antimicrobial Susceptibility Testing Market, by Product

7.      Global Antimicrobial Susceptibility Testing Market, by Application

8.      Global Antimicrobial Susceptibility Testing Market, by End User

9.      Global Antimicrobial Susceptibility Testing Market, by Geography

10. Competitive Landscape

11. Company Profiles

12. Appendix

Browse the in-depth Report at:

https://www.meticulousresearch.com/product/antimicrobial-susceptibility-testing-market-5062/

Key Questions Answered in The Report

Which are the high growth market segments in     terms of product, method, application, end-users, and region/countries?

What was the historical market for     antimicrobial susceptibility testing across the globe?

What are the market forecasts and estimates     for the period 2019-2025?

What are the major drivers, restraints,     opportunities, and challenges in the global antimicrobial susceptibility     testing market?

Who are the major players in the antimicrobial     susceptibility testing market?

How is the competitive landscape and who are     the market leaders in the global antimicrobial susceptibility testing     market?

What are the recent developments in the global     antimicrobial susceptibility testing market?

What are the different strategies adopted by     the major players in the global antimicrobial susceptibility testing     market?

What are the geographical trends and high     growth regions/ countries?